In patients with orthostatic hypotension, which medications should be tapered, discontinued, or titrated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medications to Titrate in Orthostatic Hypotension

Immediately discontinue or reduce diuretics, vasodilators (especially calcium channel blockers and alpha-blockers), and psychotropic medications that do not alter prognosis, as these are the most common culprits of drug-induced orthostatic hypotension. 1, 2

Priority Medication Review Algorithm

First-Line Medications to Discontinue or Reduce:

  1. Diuretics - Most frequent cause of drug-induced orthostatic hypotension 1

    • Stop or reduce loop diuretics first
    • Discontinue combination diuretic therapy as early as possible 3
    • Be extremely careful with multiple diuretics as they greatly increase hypotension risk 3
  2. Vasodilators that don't improve mortality:

    • Alpha-blockers (including tamsulosin for prostate) - reduce or discontinue 3, 4
    • Calcium channel blockers - reduce or discontinue if possible 3
    • Note: In heart failure patients, these can be stopped without affecting prognosis 3
  3. Psychotropic medications:

    • Tricyclic antidepressants 5
    • Phenothiazines 5
    • Trazodone 4
    • Tizanidine 4
  4. Other commonly overlooked medications:

    • Sildenafil (PDE5 inhibitors) 4
    • Carvedilol (non-selective beta-blockers worse than selective) 4
    • Chronic vasodilator therapy 1

Medications to Switch Rather Than Stop:

For patients with supine hypertension and orthostatic hypotension, switch BP-lowering medications that worsen orthostatic hypotension to alternative therapies rather than simply de-intensifying treatment. 2

  • Preferred antihypertensives in OH patients:

    • Angiotensin receptor blockers (ARBs) 4
    • Long-acting dihydropyridine calcium channel blockers 4
    • These are better tolerated than other classes
  • Avoid in OH:

    • Non-selective beta-blockers (use cardioselective if needed) 6
    • Alpha-blockers 3
    • Short-acting vasodilators

Medications to Carefully Titrate (Not Stop):

For patients requiring evidence-based therapies (heart failure, post-MI), use these strategies rather than discontinuation 3:

  1. Stagger vasoactive medications - no two drugs within 2 hours of each other 3
  2. Split into smaller, more frequent doses 3
  3. Give beta-blockers with meals to slow absorption 3
  4. Titrate more slowly and avoid titration during hypovolemia 3
  5. Administer at bedtime for short-acting antihypertensives in isolated supine hypertension 4

Special Considerations:

  • In heart failure patients: Most clinicians stop mineralocorticoid receptor antagonists (MRAs) and reassess before stopping ACE inhibitors or ARBs 3

  • In diabetic autonomic neuropathy: Avoid drugs that reduce heart rate variability; exclude medications exacerbating orthostatic hypotension before starting specific OH treatments 6, 5

  • Alcohol: Commonly associated with orthostatic intolerance through both acute CNS effects and volume depletion - avoidance is the primary strategy 1

Critical Pitfall to Avoid

Do not simply reduce all antihypertensive medications indiscriminately. Uncontrolled hypertension actually worsens orthostatic hypotension 4. The goal is selective medication optimization: eliminate drugs without mortality benefit while maintaining evidence-based therapies using the timing and dosing strategies above.

The medication review should occur before initiating pharmacological treatment for orthostatic hypotension (midodrine, droxidopa, fludrocortisone), as drug-induced autonomic failure is the most frequent cause of orthostatic hypotension 1.

References

Research

Orthostatic Hypotension in the Hypertensive Patient.

American journal of hypertension, 2018

Guideline

american association of clinical endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan-2022 update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.